Clinical Trials Browser

OTHER × Brain Neoplasms × camrelizumab × Clear all

NCT04211090 2022-11-16

CAP-BRAIN

Phase 2 Unknown

Brain Neoplasms

NCT04291092 2021-09-10

Camrelizumab Combined With Local Treatment in NSCLC Patients With BM

Phase 2 Unknown

Brain Neoplasms, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms